Streetbeat News

RVVTF

Revive Therapeutics Ltd

http://www.revivethera.com/

Industry

Medicinal and Botanical Manufacturing

Open

0.01

Mkt cap

3.1M

Volume

29K

High

0.01

P/E Ratio

-0.73

52-wk high

0.04

Low

0.01

Div yield

N/A

52-wk low

0.01

Revive Therapeutics Ltd. announced a publication demonstrating the potential of psilocybin as a novel therapeutic approach in stroke, published in BMC Neuroscience.

Portfolio Pulse from

November 12, 2024 | 1:00 pm

PATOO, a Jamaica-based psychedelic CPG brand, has partnered with Fontana Pharmacy to introduce the first legal psilocybin-infused products to Jamaican pharmacy shelves. This move marks a significant step toward broader acceptance of psychedelic wellness products. Several publicly traded companies are at the forefront of developing and commercializing psychedelic therapies, including Compass Pathways, Atai Life Sciences, Cybin Inc., Mind Medicine, Mydecine Innovations Group, Seelos Therapeutics, and Revive Therapeutics.

Portfolio Pulse from Javier Hasse

July 31, 2024 | 12:00 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.